Introduction
Assessment of dry‐weight among patients on dialysis is challenging in the absence of reliable markers to define fluid overload (FO). This study aimed to explore the value of two simple clinical signs, pedal edema, and crackles at pulmonary auscultation, in diagnosing hypervolemia, using bioimpendence spectroscopy (BIS) as reference standard.
Methods
In a cohort of 107 asymptomatic dialysis patients, FO was assessed with physical examination and BIS shortly before the mid‐week dialysis session. Patients were also asked to perform home blood pressure (BP) monitoring with a validated, automatic device (HEM‐705, Omron, Healthcare) for 1 week in order to determine their BP outside of dialysis.
Findings
Patients within the high tertile of predialysis FO had longer dialysis vintage, lower serum albumin and higher home systolic BP, despite the more aggressive treatment with a higher average number of antihypertensives daily. In receiver‐operating‐characteristic (ROC) curve analysis, pedal edema (area under curve [AUC]: 0.534; 95% confidence interval [CI]: 0.416–0.651) and pulmonary crackles (AUC: 0.551; 95% CI: 0.432–0.671) had limited accuracy in detecting excess predialysis FO > 2.2 L. The agreement of pedal edema (k‐coefficient: 0.065) and pulmonary crackles (k‐coefficient: 0.122) with BIS‐derived FO was poor. In multivariate linear regression analysis, longer dialysis vintage (β: 0.306, p < 0.001) and higher home systolic BP (β: 0.287, p < 0.01) were the two factors that were associated with predialysis FO.
Conclusions
This study showed that among asymptomatic dialysis patients, pedal edema and pulmonary crackles in physical examination had limited discriminatory power in detection of FO, as assessed with the method of BIS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.